Acute Otitis Media (AOM) Treatment and Management Market to Set Phenomenal Growth by 2026

Acute otitis media (AOM) is a common infection, which usually affects children. The disease leads to inflammation of middle-ear forming a middle-ear infusion. It is the second most common disease in children after upper respiratory tract infection. The disease exhibits symptoms such as fever, ear discharge (otorrhoe), irritability, and otalgia. Acute otitis media (AOM) affects approximately 80% children aged between 1 year and 5 years. Globally, the cumulative incidence rate of acute otitis media is 10.85%. Around 709 million cases of acute otitis media are reported across the world each year, of these 51% occur in children aged under five years. Children between 6 months and 18 months are at a high risk of getting the disease. If the disease is left untreated, it could lead to permanent hearing loss. Repeated acute otitis media episodes in an individual can result into severe complications such as hearing loss/impairment, intracranial infection, and facial paralysis. Bacteria and viruses are the causative agents of this infection.
Streptococcus pneumoniae is the major pathogen responsible for this infection. Around 35% to 55% cases of acute otitis media are caused due to bacteria and about 20% to 30% cases of acute otitis media are due to viruses.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39296

Rise in incidence of acute otitis media cases drives the global acute otitis media treatment and management market. Other factors such as increase in young maternal age, children with aboriginal ancestry, and rise in number of women who smoke during pregnancy lead to rise in the number of acute otitis media cases. This in turn propels the global acute otitis media treatment and management market. However, frequent use of antibiotics in treating acute otitis media is giving rise to antibiotic resistant strains restricting the use of certain drugs in the treatment of the disease. This hampering the growth of the acute otitis media treatment and management market.
Request a Sample of Acute Otitis Media (AOM)
Treatment and Management Market: https://www.transparencymarketresearch.com/checkout.php?rep_id=39296<ype=S

The global acute otitis media treatment and management market can be segmented based on type of medical care therapy, type of surgical care, distribution channel, and region. In terms of type of medical care therapy, the market can be categorized into antimicrobial therapy, antihistamine-decongestants drugs therapy, steroid therapy, and mucolytic drugs therapy. Based on type of surgical care, the global acute otitis media treatment and management market can be classified into tympanocentesis, myringotomy, and myringotomy. In terms of distribution channel, the market can be divided into hospitals, ENT specialist clinics, retail pharmacies, and online pharmacies.

Request for Analysis of COVID19 Impact on Acute Otitis Media (AOM) Treatment and Management Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=39296

Geographically, the global acute otitis media treatment and management market can be segmented into five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Incidence rate of acute otitis media is high in countries in the Middle East. Saudi Arabia has a high number of children affected with the disease. In less developed countries, the disease is quite common and one of the major causes of childhood mortality. Poor hygiene facilities, less health care infrastructure, and lack of awareness are the major causes of high cases of acute media otitis in the less developed and under developed nations. Increase in awareness about the disease and rise in incidence rate in other parts of the globe boost market growth. Moreover, the unmet medical need presents an opportunity for all research and development programs to invest in the global acute otitis media treatment and management market.

Pre-Book Acute Otitis Media (AOM) Treatment and Management Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=39296<ype=S

Key players in the global acute otitis media treatment and management market include Eli Lilly and Company, Pfizer, Inc., Abbott, GlaxoSmithKline plc, Janssen Pharmaceuticals, Sanofi, Bayer AG, Novartis AG, Astellas Pharma, Inc. and Bristol Myers Squibb Company.

Read More Reports: https://www.prnewswire.com/news-releases/growing-prevalence-of-urologic-diseases-to-drive-growth-in-foley-catheters-market-from-2019-to-2027-tmr-301114123.html

Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of analysts, researchers, and consultants who use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

This release was published on openPR.